Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Debopam Samanta

Concepts (340)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
30
2025
184
13.000
 Why?
Anticonvulsants
20
2025
133
8.790
 Why?
Seizures
24
2025
203
6.150
 Why?
Tuberous Sclerosis
8
2025
39
4.240
 Why?
Spasms, Infantile
11
2025
30
4.120
 Why?
Cannabidiol
8
2025
43
3.930
 Why?
Status Epilepticus
6
2021
32
3.270
 Why?
Epilepsies, Myoclonic
5
2024
14
3.020
 Why?
Mutation
16
2023
1318
3.000
 Why?
Deep Brain Stimulation
4
2025
43
2.760
 Why?
Humans
119
2026
52114
2.690
 Why?
Electroencephalography
18
2024
296
2.470
 Why?
Child
44
2026
7147
2.290
 Why?
Intellectual Disability
5
2023
128
2.140
 Why?
Brain
10
2024
1311
2.090
 Why?
Hemiplegia
3
2021
12
1.960
 Why?
Developmental Disabilities
5
2019
121
1.640
 Why?
Epilepsy, Absence
3
2019
11
1.600
 Why?
Magnetic Resonance Imaging
16
2025
1518
1.580
 Why?
Infant
24
2025
3660
1.550
 Why?
Genetic Therapy
2
2025
124
1.450
 Why?
Algorithms
2
2025
663
1.370
 Why?
Tumor Suppressor Proteins
3
2023
128
1.360
 Why?
Neuroaxonal Dystrophies
2
2022
8
1.360
 Why?
Nervous System Malformations
3
2020
16
1.350
 Why?
Folate Receptor 1
2
2022
27
1.320
 Why?
Child, Preschool
22
2025
4001
1.290
 Why?
Infant, Newborn, Diseases
2
2020
57
1.240
 Why?
Epilepsies, Partial
2
2022
14
1.240
 Why?
Ketamine
2
2020
59
1.230
 Why?
Vagus Nerve Stimulation
2
2025
14
1.130
 Why?
Neurocutaneous Syndromes
2
2019
6
1.120
 Why?
Cadherins
2
2019
62
1.100
 Why?
Cerebral Arteries
2
2019
30
1.030
 Why?
Male
39
2026
26652
1.020
 Why?
Epilepsy, Generalized
2
2023
9
1.010
 Why?
Vigabatrin
3
2024
3
1.000
 Why?
Female
35
2026
28055
0.990
 Why?
Sirolimus
2
2017
72
0.980
 Why?
Tic Disorders
1
2026
3
0.980
 Why?
Angiofibroma
2
2015
5
0.960
 Why?
Facial Neoplasms
2
2015
22
0.940
 Why?
Treatment Outcome
13
2025
5456
0.930
 Why?
Nerve Tissue Proteins
2
2018
192
0.930
 Why?
Valproic Acid
2
2022
35
0.920
 Why?
Neurosurgical Procedures
2
2025
134
0.920
 Why?
Stroke
3
2019
514
0.890
 Why?
Fenfluramine
2
2024
7
0.880
 Why?
Randomized Controlled Trials as Topic
2
2024
608
0.870
 Why?
Dioxolanes
2
2024
15
0.870
 Why?
Thalamus
1
2024
33
0.860
 Why?
Pregnanolone
2
2023
6
0.840
 Why?
Adolescent
17
2026
6681
0.790
 Why?
Landau-Kleffner Syndrome
1
2022
3
0.790
 Why?
Quality Improvement
2
2022
223
0.760
 Why?
Aphasia
1
2022
33
0.750
 Why?
Nervous System Diseases
2
2021
94
0.730
 Why?
Chromosome Deletion
3
2019
139
0.730
 Why?
Abnormalities, Multiple
3
2023
168
0.720
 Why?
Emergencies
1
2021
80
0.690
 Why?
Pharmaceutical Preparations
1
2021
73
0.690
 Why?
Angelman Syndrome
1
2020
1
0.680
 Why?
Transition to Adult Care
1
2020
19
0.670
 Why?
Bone Diseases, Developmental
2
2023
17
0.660
 Why?
Tooth Abnormalities
2
2023
13
0.660
 Why?
Immunoglobulins, Intravenous
1
2021
63
0.650
 Why?
Oligonucleotides, Antisense
1
2020
29
0.640
 Why?
Phenobarbital
1
2020
17
0.640
 Why?
Flunarizine
1
2019
1
0.640
 Why?
Behavioral Symptoms
1
2019
4
0.640
 Why?
Immunologic Factors
1
2021
117
0.640
 Why?
Excitatory Amino Acid Antagonists
1
2020
45
0.640
 Why?
Ocular Physiological Phenomena
1
2019
3
0.630
 Why?
Tetrasomy
1
2019
2
0.620
 Why?
Agenesis of Corpus Callosum
2
2018
9
0.620
 Why?
Chromosomes, Human, Pair 5
1
2019
17
0.620
 Why?
Sneddon Syndrome
1
2019
3
0.620
 Why?
Livedo Reticularis
1
2019
5
0.620
 Why?
Calcium Channel Blockers
1
2019
60
0.620
 Why?
Oral Ulcer
1
2019
3
0.620
 Why?
Behcet Syndrome
1
2019
7
0.610
 Why?
Transposases
1
2019
10
0.610
 Why?
Andersen Syndrome
1
2019
1
0.610
 Why?
Spinal Cord Diseases
1
2019
39
0.600
 Why?
Hydrocephalus
1
2019
43
0.600
 Why?
Receptors, GABA-B
1
2019
10
0.600
 Why?
Vitiligo
1
2019
8
0.600
 Why?
Leukoencephalopathies
1
2019
14
0.600
 Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.600
 Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.590
 Why?
Edema
1
2019
64
0.590
 Why?
Migraine Disorders
2
2020
44
0.590
 Why?
Physicians
1
2022
235
0.590
 Why?
Cerebral Infarction
1
2018
34
0.590
 Why?
Electron Transport Complex IV
1
2018
24
0.590
 Why?
Muscle Weakness
1
2019
45
0.590
 Why?
Optic Atrophy
1
2018
13
0.590
 Why?
Nephrotic Syndrome
2
2017
34
0.580
 Why?
Cannabinoid Receptor Agonists
1
2019
50
0.580
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.580
 Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.580
 Why?
Photic Stimulation
1
2018
56
0.580
 Why?
Alopecia
1
2019
38
0.580
 Why?
Shab Potassium Channels
1
2018
2
0.580
 Why?
Brain Edema
1
2018
36
0.570
 Why?
Parents
1
2021
334
0.570
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
30
0.560
 Why?
Artifacts
1
2018
54
0.560
 Why?
Thrombocytopenia
1
2019
93
0.560
 Why?
Myoclonus
1
2018
9
0.560
 Why?
Autoimmune Diseases
1
2019
86
0.560
 Why?
Biomedical Research
1
2021
262
0.560
 Why?
Mitochondrial Diseases
1
2018
45
0.550
 Why?
Neurodegenerative Diseases
1
2018
81
0.540
 Why?
Practice Guidelines as Topic
1
2020
494
0.540
 Why?
Hearing Loss, Sensorineural
1
2018
78
0.530
 Why?
Health Knowledge, Attitudes, Practice
1
2021
503
0.530
 Why?
Immunologic Deficiency Syndromes
1
2017
17
0.530
 Why?
Osteochondrodysplasias
1
2017
14
0.530
 Why?
Models, Biological
1
2020
731
0.530
 Why?
Arteriosclerosis
1
2017
50
0.520
 Why?
Infant, Newborn
6
2024
2859
0.520
 Why?
Carotid Artery Diseases
1
2017
31
0.520
 Why?
Phenotype
2
2021
794
0.520
 Why?
Drug Discovery
1
2017
93
0.510
 Why?
Child Development
1
2018
201
0.510
 Why?
Prenatal Exposure Delayed Effects
1
2018
193
0.500
 Why?
Cafe-au-Lait Spots
1
2016
2
0.500
 Why?
Skin
1
2019
418
0.490
 Why?
Williams Syndrome
1
2016
25
0.490
 Why?
Migraine with Aura
1
2015
4
0.490
 Why?
Erythema Infectiosum
1
2015
3
0.490
 Why?
Corpus Callosum
2
2023
26
0.490
 Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.490
 Why?
Pulmonary Embolism
1
2017
83
0.490
 Why?
Syndrome
6
2024
247
0.480
 Why?
Sinus Pericranii
1
2015
1
0.480
 Why?
Parvovirus B19, Human
1
2015
16
0.480
 Why?
Toes
1
2015
15
0.480
 Why?
Electrodiagnosis
1
2015
13
0.480
 Why?
SOS1 Protein
1
2015
2
0.480
 Why?
Crying
1
2015
4
0.480
 Why?
Moyamoya Disease
1
2015
7
0.480
 Why?
Hyperventilation
1
2015
8
0.480
 Why?
Iatrogenic Disease
1
2015
26
0.470
 Why?
Tuberculoma
1
2015
1
0.470
 Why?
Epilepsy, Benign Neonatal
1
2015
2
0.470
 Why?
Noonan Syndrome
1
2015
12
0.470
 Why?
Neurologic Examination
1
2015
73
0.470
 Why?
Encephalitis
1
2016
39
0.470
 Why?
Communication
3
2022
254
0.470
 Why?
Ocular Motility Disorders
1
2015
16
0.460
 Why?
Mutism
1
2015
3
0.460
 Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.460
 Why?
Retrospective Studies
9
2026
6610
0.460
 Why?
Repressor Proteins
2
2023
150
0.460
 Why?
TOR Serine-Threonine Kinases
1
2015
82
0.460
 Why?
Diagnosis, Differential
7
2020
1031
0.460
 Why?
Trisomy
1
2014
35
0.450
 Why?
Neurology
1
2015
33
0.440
 Why?
Influenza, Human
1
2015
85
0.440
 Why?
KCNQ2 Potassium Channel
1
2014
8
0.440
 Why?
Energy Drinks
1
2014
6
0.440
 Why?
Vasoconstriction
1
2014
56
0.430
 Why?
Benzodiazepines
1
2014
71
0.430
 Why?
Osteomyelitis
1
2015
125
0.420
 Why?
Membrane Proteins
1
2016
328
0.420
 Why?
Sleep
1
2014
185
0.400
 Why?
Enzyme Inhibitors
1
2015
371
0.400
 Why?
Quality of Life
4
2025
878
0.390
 Why?
Magnetic Resonance Angiography
3
2019
67
0.380
 Why?
Immunosuppressive Agents
3
2019
249
0.370
 Why?
Consensus
2
2025
190
0.370
 Why?
Pediatrics
1
2015
291
0.360
 Why?
Receptors, N-Methyl-D-Aspartate
2
2022
75
0.340
 Why?
Clinical Trials as Topic
2
2024
463
0.330
 Why?
Diffusion Magnetic Resonance Imaging
3
2017
132
0.330
 Why?
Caregivers
2
2021
236
0.300
 Why?
Recurrence
3
2019
680
0.300
 Why?
Echinocandins
1
2008
64
0.290
 Why?
Mycoses
1
2008
152
0.270
 Why?
Gastroesophageal Reflux
2
2019
48
0.260
 Why?
Antifungal Agents
1
2008
346
0.240
 Why?
Administration, Topical
2
2015
60
0.240
 Why?
Adult
6
2025
14095
0.230
 Why?
Seizures, Febrile
1
2024
2
0.230
 Why?
Meta-Analysis as Topic
1
2024
39
0.220
 Why?
Magnetoencephalography
1
2025
88
0.220
 Why?
Memory, Short-Term
1
2025
74
0.220
 Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.220
 Why?
Psychosurgery
1
2023
5
0.210
 Why?
Databases, Factual
2
2024
714
0.210
 Why?
Comorbidity
1
2026
628
0.210
 Why?
Laser Therapy
1
2023
76
0.200
 Why?
Speech Disorders
1
2022
16
0.200
 Why?
Ethosuximide
1
2022
5
0.190
 Why?
Clonazepam
1
2022
6
0.190
 Why?
Electrodes, Implanted
1
2022
32
0.190
 Why?
Cluster Analysis
1
2023
236
0.190
 Why?
Stereotaxic Techniques
1
2022
40
0.190
 Why?
Death, Sudden
1
2022
9
0.190
 Why?
GTPase-Activating Proteins
1
2022
25
0.190
 Why?
Palliative Care
1
2024
195
0.180
 Why?
Concept Formation
1
2021
12
0.180
 Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.180
 Why?
Freedom
1
2021
3
0.180
 Why?
Folic Acid
1
2022
136
0.180
 Why?
Diazepam
1
2021
18
0.180
 Why?
Drug Interactions
1
2022
201
0.180
 Why?
Fibroma
1
2021
40
0.180
 Why?
Adrenocorticotropic Hormone
2
2022
30
0.170
 Why?
Personal Satisfaction
1
2021
74
0.170
 Why?
Risk Factors
2
2020
3922
0.170
 Why?
Soft Tissue Neoplasms
1
2021
55
0.170
 Why?
Brain Diseases
1
2021
78
0.170
 Why?
Dihydroergotamine
1
2020
5
0.170
 Why?
Transcription Factors
2
2023
564
0.170
 Why?
Perception
1
2021
120
0.170
 Why?
Mental Disorders
1
2025
426
0.170
 Why?
Facies
2
2023
36
0.160
 Why?
Diet Therapy
1
2020
8
0.160
 Why?
Genetic Diseases, Inborn
1
2020
24
0.160
 Why?
Clinical Protocols
1
2020
106
0.160
 Why?
Treatment Failure
1
2020
122
0.160
 Why?
Anesthetics
1
2020
36
0.160
 Why?
Learning
1
2021
156
0.160
 Why?
Leukomalacia, Periventricular
1
2019
12
0.160
 Why?
Muscle Hypotonia
1
2019
23
0.160
 Why?
Chromosomes, Human, Pair 7
1
2019
29
0.160
 Why?
Matrix Attachment Region Binding Proteins
1
2020
37
0.150
 Why?
HLA-B51 Antigen
1
2019
2
0.150
 Why?
Qualitative Research
1
2021
358
0.150
 Why?
Ventriculoperitoneal Shunt
1
2019
28
0.150
 Why?
Analgesics, Non-Narcotic
1
2020
117
0.150
 Why?
Craniofacial Abnormalities
1
2019
27
0.150
 Why?
Patient-Centered Care
1
2021
139
0.150
 Why?
Ubiquitin-Protein Ligases
1
2020
136
0.150
 Why?
Heart Septal Defects, Atrial
1
2019
44
0.150
 Why?
Disease Management
1
2020
185
0.150
 Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.150
 Why?
Ventricular Premature Complexes
1
2019
6
0.150
 Why?
Microcephaly
1
2019
40
0.150
 Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.150
 Why?
Facial Nerve Diseases
1
2018
6
0.150
 Why?
Referral and Consultation
1
2021
288
0.150
 Why?
Syncope
1
2019
31
0.150
 Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.150
 Why?
Cerebral Veins
1
2018
17
0.150
 Why?
Facial Paralysis
1
2018
25
0.140
 Why?
Anti-Arrhythmia Agents
1
2019
81
0.140
 Why?
Health Personnel
1
2021
251
0.140
 Why?
Deglutition Disorders
1
2019
76
0.140
 Why?
Acute Disease
1
2019
386
0.140
 Why?
Fatal Outcome
1
2019
192
0.140
 Why?
Video Recording
1
2018
78
0.140
 Why?
Fibrinolytic Agents
1
2019
131
0.140
 Why?
Frameshift Mutation
1
2018
18
0.140
 Why?
Combined Modality Therapy
1
2020
634
0.140
 Why?
Anti-Inflammatory Agents
1
2019
166
0.140
 Why?
Fear
1
2018
80
0.140
 Why?
India
1
2017
58
0.140
 Why?
Cerebellum
1
2018
120
0.140
 Why?
History, 21st Century
1
2017
58
0.130
 Why?
Platelet Aggregation Inhibitors
1
2019
211
0.130
 Why?
History, 20th Century
1
2017
95
0.130
 Why?
Neurotoxicity Syndromes
1
2017
46
0.130
 Why?
Methotrexate
1
2017
77
0.130
 Why?
Pandemics
1
2021
579
0.130
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
90
0.130
 Why?
Animals
3
2022
13332
0.130
 Why?
Anti-Infective Agents
1
2017
106
0.130
 Why?
Aldehyde Dehydrogenase
1
2016
24
0.120
 Why?
Hormones
1
2016
59
0.120
 Why?
Influenza B virus
1
2015
6
0.120
 Why?
Delayed Diagnosis
1
2016
29
0.120
 Why?
Arkansas
1
2021
2016
0.120
 Why?
Chromosomes, Human, Pair 3
1
2015
18
0.120
 Why?
North America
1
2015
75
0.120
 Why?
Cerebral Angiography
1
2015
90
0.110
 Why?
Antibiotics, Antineoplastic
1
2015
79
0.110
 Why?
Complementary Therapies
1
2015
23
0.110
 Why?
Chromosomes, Human, Pair 9
1
2014
20
0.110
 Why?
Brain Waves
1
2014
19
0.110
 Why?
Drug Resistance
1
2015
68
0.110
 Why?
Antiemetics
1
2014
32
0.110
 Why?
Polymerase Chain Reaction
1
2015
460
0.110
 Why?
Headache
1
2014
75
0.110
 Why?
Vomiting
1
2014
71
0.110
 Why?
Glutamine
1
2015
176
0.110
 Why?
Mutation, Missense
1
2014
108
0.110
 Why?
Arginine
1
2015
178
0.100
 Why?
Decision Making, Computer-Assisted
1
2013
3
0.100
 Why?
Analgesics
1
2014
103
0.100
 Why?
Diagnostic Errors
1
2013
69
0.100
 Why?
Evidence-Based Medicine
1
2013
270
0.090
 Why?
Inflammation
1
2016
641
0.090
 Why?
Pregnancy
1
2018
2658
0.090
 Why?
Signal Transduction
1
2017
1699
0.080
 Why?
Antineoplastic Agents
1
2017
1214
0.080
 Why?
Dysentery
1
2009
1
0.080
 Why?
Trichuriasis
1
2009
1
0.080
 Why?
Trichuris
1
2009
1
0.080
 Why?
Anesthesia, Intravenous
1
2008
12
0.070
 Why?
Eosinophils
1
2009
40
0.070
 Why?
Lipopeptides
1
2008
61
0.070
 Why?
Amyloidosis
1
2009
85
0.070
 Why?
Tuberculosis
1
2009
131
0.070
 Why?
Candidiasis
1
2008
113
0.070
 Why?
Aspergillosis
1
2008
122
0.070
 Why?
Inflammatory Bowel Diseases
1
2009
85
0.070
 Why?
Prospective Studies
2
2023
2424
0.060
 Why?
Kidney Diseases
1
2009
229
0.060
 Why?
Clinical Trials, Phase III as Topic
1
2025
48
0.060
 Why?
Observer Variation
1
2024
131
0.050
 Why?
Spasm
1
2024
9
0.050
 Why?
Feedback
1
2024
52
0.050
 Why?
Kaplan-Meier Estimate
1
2025
482
0.050
 Why?
Probability
1
2023
171
0.050
 Why?
Young Adult
2
2025
4307
0.050
 Why?
Neuroimaging
1
2023
93
0.050
 Why?
Pilot Projects
1
2025
712
0.050
 Why?
Potassium Channels
1
2021
31
0.040
 Why?
Reproducibility of Results
1
2024
1214
0.040
 Why?
Registries
1
2024
629
0.040
 Why?
Administration, Intravenous
1
2020
73
0.040
 Why?
Sleep Stages
1
2020
40
0.040
 Why?
Age of Onset
1
2020
109
0.040
 Why?
Cognition
1
2022
332
0.040
 Why?
Follow-Up Studies
1
2025
2282
0.040
 Why?
Immunohistochemistry
1
2021
975
0.040
 Why?
Aged
1
2025
10142
0.020
 Why?
Software
1
2013
280
0.020
 Why?
Internet
1
2013
260
0.020
 Why?
Middle Aged
1
2025
13028
0.020
 Why?
Mebendazole
1
2009
2
0.020
 Why?
Antinematodal Agents
1
2009
3
0.020
 Why?
Leukemoid Reaction
1
2009
6
0.020
 Why?
Antitubercular Agents
1
2009
84
0.020
 Why?
Colonoscopy
1
2009
107
0.020
 Why?
Prognosis
1
2009
2093
0.010
 Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (340) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department